Login

Balance sheets

In millions of USD, except per-share amounts
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Cash
Prepaid expense
Total Current Assets
Deferred offering costs
Investment held in trust account
Ordinary Share
Total investment held in trust account
Total Assets
Current Liabilities
Amount due to a related party
Accrued expense
Promissory note, related party
Amount due to related party
Promissory note, third party
Ordinary shares subject to redemption
Other payable and accrued expenses
Over-allotment liability
Total Current Liabilities
Total Liabilities
Commitments and Contingencies (Note 6)
Commitments and Contingencies (Note 7)
Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 2,180,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025 (excluding 3,502,404 shares subject to redemption and 178,285 shares subject to possible redemption as of March 31, 2026 and 6,900,000 shares subject to possible redemption as of December 31, 2025), respectively
Shareholder's Deficit:
Preferred share, $0.0001 par value, 10,000,000 shares authorized, none issued and outstanding
Ordinary shares, $0.0001 par value, 490,000,000 shares authorized, 2,180,000 shares issued and outstanding as of March 31,2026 and December 31,2025 (excluding 3,680,689 and 6,900,000 shares subject to possible redemption)
Additional paid-in capital
Subscription receivable
Accumulated deficit
Total Shareholder's Deficit
Total Liabilities Ordinary Shares Subject to Possible Redemptions and Shareholder's Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support